RX-5902 Treatment of Subjects With Triple Negative Breast Cancer
Clinical trial NCT02003092 · TERMINATED
Trial details
- NCT number
- NCT02003092
- Sponsor
- Rexahn Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2019-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.